Logo
Chat on WhatsApp

CDSCO License for Flexible fibreoptic laparoscope

Medical Device Information

Device Class
Class B

Intended Use

For the visual examination and treatment of the abdominal/retroperitoneal cavity and its organs

Manufacturing License
MD5
Import License
MD15
CDSCO License for Flexible fibreoptic laparoscope

Introduction to Flexible Fibreoptic Laparoscope and Regulatory Importance

Flexible fibreoptic laparoscopes are critical medical devices used in the visual examination and treatment of the abdominal and retroperitoneal cavities, primarily in obstetrical and gynecological procedures. Given their invasive nature and direct contact with sterile body sites, these devices are classified as Class B under the CDSCO medical device classification, reflecting moderate risk to patients.

Navigating India's regulatory landscape for such devices is essential to ensure market access, compliance with safety standards, and uninterrupted supply. With over 25 years of regulatory consulting experience and having supported 500+ companies, we understand the nuances involved in securing the CDSCO manufacturing license and import license for flexible fibreoptic laparoscopes.

CDSCO Regulatory Framework for Flexible Fibreoptic Laparoscopes

The Central Drugs Standard Control Organisation (CDSCO) regulates medical devices in India under the Medical Device Rules, 2017. Flexible fibreoptic laparoscopes fall under the Obstetrical and Gynecological category, notified via File No. 29/Misc./03/2020-DC (181) dated 03.6.2022.

For Class B devices like flexible fibreoptic laparoscopes, the regulatory pathway involves obtaining an MD5 manufacturing license if producing domestically, or an MD15 import license for imported devices.

Risk Classification and License Requirements

  • Device: Flexible fibreoptic laparoscope
  • Risk Class: B (Moderate risk)
  • License Required: MD5 Manufacturing License (for manufacturers)
  • Regulatory Authority: State Licensing Authority

Class B devices require a rigorous but streamlined process involving testing, documentation, and audit by notified bodies. Understanding these requirements upfront can save months in approval delays.

Manufacturing License Process (MD5)

The MD5 license process for flexible fibreoptic laparoscopes typically takes 3-4 months and involves the following steps:

  1. Test License (Form MD13): Apply for a test license to manufacture the device samples for testing. This process takes approximately 1.5-2 months.
  2. Product Testing: Get your device tested at CDSCO-approved government laboratories to verify safety and performance.
  3. Documentation Preparation: Compile all required documents including Device Master File, Plant Master File, and Quality Management System (QMS) documents.
  4. License Application (Form MD3): Submit the manufacturing license application through the CDSCO MD Online Portal.
  5. Audit by Notified Body: An audit by a notified body is conducted to verify compliance with Good Manufacturing Practices.
  6. Query Resolution: Respond promptly to any queries from the CDSCO or notified body.
  7. Grant of License (Form MD5): Upon satisfactory compliance, the MD5 manufacturing license is granted.

Manufacturing License Documents Required

For flexible fibreoptic laparoscopes, you must prepare the following key documents:

  • Certificate of Incorporation and Company Constitution
  • Proof of Ownership or Tenancy of Manufacturing Premises
  • Qualification and Experience Details of Technical Staff
  • Fire and Pollution NOCs
  • Device Master File detailing design, specifications, and manufacturing process (Device Master File Guide)
  • Plant Master File describing manufacturing facilities (Plant Master File Guide)
  • Essential Principles Checklist ensuring compliance with safety standards
  • Risk Management File documenting hazard analysis and mitigation (Risk Management)
  • Test Reports from CDSCO-approved laboratories (Testing Laboratories)
  • Product Labels and Instructions for Use (IFU)
  • Quality Management System (QMS) Documents, preferably ISO 13485:2016 certification

Import License Process (MD15)

For importers of flexible fibreoptic laparoscopes into India, the MD15 import license is mandatory. The process is managed by the Central Licensing Authority and typically takes 5-6 months due to extensive documentation and review.

Steps include:

  1. Document Preparation: Assemble all required documents including manufacturing license from the country of origin, Free Sale Certificate, ISO 13485:2016, CE Certificate, Device Master File, Plant Master File, and Wholesale License.
  2. Application Submission: Submit Form MD14 through the CDSCO MD Online Portal.
  3. Query Resolution: Address any CDSCO queries promptly.
  4. Grant of License: Upon clearance, an MD15 import license is issued.

Note that a test license is not required for import applications.

Import License Documents Required

  • Valid Manufacturing License of the foreign manufacturer
  • Free Sale Certificate from the country of origin
  • ISO 13485:2016 certification
  • CE Certificate or equivalent
  • Device Master File
  • Plant Master File
  • Wholesale License for distribution in India
  • Company Constitution and Registration Documents

Timeline and Processing Duration

Process StageEstimated Duration
Test License (MD13)1.5 - 2 months
Product Testing2 - 3 weeks
Documentation Preparation2 - 4 weeks
Application Submission & Audit1 - 1.5 months
Query Resolution2 - 4 weeks
Total MD5 License Timeline3 - 4 months

For importers applying for MD15 license, expect around 5-6 months total processing time.

Government Fees and Costs

  • MD5 Manufacturing License:

    • Application Fee: Rs. 5,000
    • Per Product Fee: Rs. 500
  • MD15 Import License: (for Class B devices)

    • Site Fee: $2,000
    • Per Product Fee: $1,000

Additional costs may include testing fees at government labs and notified body audit charges.

Common Challenges and Solutions

  • Delayed Testing Results: Collaborate early with CDSCO-approved labs to schedule testing and avoid bottlenecks.
  • Incomplete Documentation: Utilize comprehensive checklists and expert consultation to ensure all documents are error-free.
  • Audit Non-Compliance: Conduct internal audits and pre-audit training with your team before the notified body visit.
  • Query Delays: Assign dedicated personnel to monitor and respond promptly to CDSCO queries.

Expert Consultation and Support

Our seasoned regulatory team has successfully guided over 500 companies through the CDSCO licensing maze. We offer tailored support from initial classification to final license grant, including:

  • Gap analysis of existing documentation
  • Device Master File and Plant Master File preparation
  • Liaison with notified bodies and CDSCO
  • Mock audits and training sessions
  • Post-license compliance and renewal assistance

Getting Started with Your CDSCO License Application

  1. Assess Your Device Classification: Confirm your device is Class B by reviewing the Medical Device Classification.
  2. Prepare Test License Application: Gather key documents and apply for the MD13 test license via the CDSCO MD Online Portal.
  3. Coordinate Product Testing: Identify government-approved testing laboratories early to schedule your device tests.
  4. Develop Documentation: Assemble your Device Master File, Plant Master File, Risk Management File, and Quality Management System documents.
  5. Plan for Audit: Schedule your notified body audit once testing and documentation are ready.
  6. Submit MD5 License Application: Apply through the online portal and prepare to respond to any queries.

Starting early and leveraging expert guidance ensures a smooth journey towards obtaining your CDSCO license for flexible fibreoptic laparoscopes. Reach out to our regulatory consulting team to expedite your approval process and enter the Indian market with confidence.

Get Expert Help

Free consultation for your medical device license

24/7 Support Available

Why Choose Us

500+ Licenses Obtained
100% Success Rate
15+ Years Experience
24/7 Support Available

About the Author

avatar
Tails Azimuth
@Twitter